← Back to catalogue
Published

estradiol valerate

vr.tr.estradiol-valerate · thing-q5401768

Enable an agent to identify estradiol valerate, assess a material lot's quality and condition, and determine whether evidence supports its intended handling or use.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 18 findings · 31 questions

Ester identity Establishes exactly which estradiol derivative the registry entry denotes.

Molecular boundary

Defines the ester attachment and stereochemical identity.

Reference structure

Require a reference structure and analytical evidence that discriminate estradiol valerate from neighbouring steroid identities.

  1. Which reference structure establishes the pentanoate attachment position and complete stereochemistry? definition
  2. Which analytical results distinguish this sample from free estradiol, positional isomers and other estradiol esters? measurement

Identifier resolution

Connects the registry entry to independently maintained substance records.

Substance record mapping

Map chemical identifiers to the defined molecule while keeping product identifiers separate.

  1. Which read sources verify the CAS number, PubChem CID, EC number and UNII for this exact structure? provenance
  2. Does a supplied name or identifier denote estradiol valerate itself, a mixture, a reference solution or a finished medicine? boundary
Lot composition and grade Determines what a particular estradiol valerate lot contains and what its documentation supports.

Assay and related substances

Separates intact ester content from impurities and measurement conventions.

Intact ester content

Record a specific assay and impurity profile rather than treating a supplier purity claim as complete evidence.

  1. What is the estradiol valerate assay, on what correction basis, and does the method separate free estradiol? measurement
  2. Which steroid-related impurities, residual solvents and water levels were measured, with what reporting limits? measurement

Qualification and traceability

Links material grade to a specific lot and applicable acceptance criteria.

Supported material use

Assess intended-use suitability from traceable specifications and qualification evidence.

  1. Which manufacturer lot, certificate and specification edition support the claimed grade? provenance
  2. Does the available evidence support reference testing, research or pharmaceutical processing, and which release decisions remain with another model? action
Physical form and compatibility Captures the material properties needed to assess estradiol valerate under actual conditions.

Solid state and thermal behaviour

Characterises the observed material without presuming unverified polymorphs or constants.

Conditioned physical identity

Record observed phase, any demonstrated solid form and qualified thermal measurements.

  1. What phase, solid-form evidence and particle-size distribution describe this lot under the recorded conditions? measurement
  2. What measured melting interval and decomposition behaviour are supported, and is any reported boiling point experimental or estimated? provenance

Solvent and matrix behaviour

Relates measured dissolution and compatibility to explicitly identified media.

Qualified solubility

Keep equilibrium solubility and compatibility evidence distinct from a finished product's labelled concentration.

  1. What estradiol valerate solubility was measured in the relevant solvent or vehicle, at what temperature and equilibration conditions? measurement
  2. Which precipitation or compatibility conclusions apply to the substance, and which depend on a particular formulation? boundary
Ester transformation and stability Tracks intact ester, transformation products and the evidence needed to retain material acceptance.

Conversion to estradiol

Defines the relationship between ester transformation and the resulting estradiol species.

Conversion evidence and quantity basis

Require evidence for conversion conditions and distinguish chemical amount equivalence from therapeutic equivalence.

  1. Which studies establish estradiol valerate conversion products and rates in specified chemical or biological conditions? provenance
  2. Is a reported quantity intact ester mass, molar amount or estradiol-equivalent mass, and how was it derived? measurement
  3. Which conclusions about exposure or duration require a route-specific product model rather than molecular identity alone? boundary

Degradation and retest

Connects storage history to evidence of continuing ester quality.

Stability-supported disposition

Base retest or rejection on relevant stability data and a method capable of detecting degradation.

  1. Which studies establish changes in intact ester and degradants under relevant heat, light, moisture and container conditions? provenance
  2. Given this lot's storage history and retest date, what evidence supports continued acceptance, quarantine or retesting? action
Hazards and use boundaries Establishes evidence-based handling constraints and links substance identity to regulated uses.

Substance exposure controls

Resolves hazard evidence for the actual material and handling operation.

Applicable hazard assessment

Record classifications and exposure-control bases with their source, material scope and jurisdiction.

  1. Which current safety data and authoritative assessments apply to this grade of estradiol valerate, and where do classifications disagree? provenance
  2. Is there an authoritative occupational exposure limit or a documented internal limit, and what averaging period and units apply? measurement
  3. Which containment, protective equipment and waste controls follow from the assessed powder, solution or spill exposure? action

Ingredient, product and jurisdiction

Separates the substance's regulatory records from permissions attached to particular medicines.

Bounded use authorization

Link relevant ingredient requirements and product authorizations without treating either as unrestricted permission to use a lot.

  1. Which ingredient standards or restrictions apply in the intended jurisdiction as of the recorded date? provenance
  2. Which containing product owns the route, concentration, sterility requirements and authorization being relied upon? boundary
  3. What additional product qualification is required before this material can enter the intended regulated use? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Standards and regulation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these standards and regulation hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these regional variation hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of estradiol valerate this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT

What it is Filled

Estradiol valerate is the 17β-valerate ester of estradiol, a synthetic steroidal estrogen prodrug that is hydrolysed in the body to estradiol and valeric acid.

In scope

  • Estradiol valerate molecular identity, stereochemistry and authoritative identifiers
  • Material grade, assay, related substances and lot provenance
  • Physical form and measured properties under specified conditions
  • Ester transformation, degradation and storage stability
  • Substance hazards, exposure controls and jurisdiction-specific identity
  • Relations to estradiol and products containing estradiol valerate

Out of scope

  • Finished tablet or injectable formulation composition and product release
  • Patient-specific prescribing, dosing and monitoring
  • Estradiol, other estradiol esters and their independent substance models
  • Manufacturing equipment, synthesis procedures and facility qualification
  • Disease models and general estrogen physiology

Why it exists Filled

Enable an agent to identify estradiol valerate, assess a material lot's quality and condition, and determine whether evidence supports its intended handling or use.

Distinguishing features Filled

  • Confirm the 17β-pentanoate ester of estradiol, distinguishing ester position and stereochemistry from similarly named steroids. [DailyMed description](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66f40ab0-4432-4e85-b709-a0bc076868c6)
  • Check formula C23H32O3 and molecular mass 356.50 g/mol as supporting identity tests, without treating either as sufficient structural proof. [DailyMed description](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66f40ab0-4432-4e85-b709-a0bc076868c6)
  • Require an analytical method that distinguishes intact estradiol valerate from unesterified estradiol and other estradiol esters.
  • Distinguish the substance from a medicine containing it: an oil injection includes vehicle and possibly preservatives beyond estradiol valerate. [DailyMed formulation description](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66f40ab0-4432-4e85-b709-a0bc076868c6)

What robots and AI may and may not do Filled

Must not

  • Recommend it, a dose or a regimen for a person.
  • Supply it outside the regulated prescription chain.
  • Advise self-administration of injections without a prescriber.
  • Disclose a person's hormone treatment, gender identity or reproductive history without consent.

Only with a human decision

  • Starting, stopping or changing hormone treatment for any person.

May

  • Describe estradiol valerate and its approved uses from medicines information.
  • Report authorization status and labelled warnings for a stated country.

Moral aspects Filled

  • Hormone treatment touches on gender identity and reproductive health, which are deeply private.
  • It carries risks such as blood clots that require medical oversight.

Who is affected

  • Patients, including transgender people and women in menopause
  • Prescribers

Owners Filled

Steward

The marketing authorization holder; medicines regulators and prescribers control its use.

Master systems

  • Medicines regulators' product registers

Links to other meta-models Filled

parent

  • Q177911 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.estradiol-valerate
  • Wikidata: Q5401768 (https://www.wikidata.org/wiki/Q5401768)

Direct properties required Filled

  • Registry and chemical identity: vr.tr.estradiol-valerate; PubChem CID 13791; verified CAS, EC and UNII mappings with source dates
  • Ester position and stereochemistry: Reference molecular structure with explicit stereochemistry and 17-pentanoate attachment
  • Grade and specification: Research material, analytical reference material or pharmaceutical material; named specification and edition
  • Estradiol valerate assay: % mass fraction, with as-is or corrected basis, method and uncertainty
  • Related substances and residuals: Individual and total impurities in % or mg/kg; residual solvents in mg/kg; water in %
  • Physical form and particle attributes: Observed phase, identified solid form and particle-size distribution in µm, with conditions
  • Thermal and solubility properties: Melting interval and decomposition onset in °C; solubility in mg/mL with solvent and temperature; boiling data only with pressure and evidence
  • Storage and retest condition: Container, temperature history, light and moisture exposure, retest date and excursion assessment
  • Hazard and exposure classification: Source-specific GHS classes, jurisdiction, revision date and exposure limits in the source's stated units

Recognition required Filled

  • Supplied as tablets or an oily solution for injection; identified by label.

Capabilities and actions required Filled

  • Match a labelled sample to the estradiol valerate reference identity and flag analytical inconsistencies.
  • Compare a lot's assay and impurity results with a named specification.
  • Select applicable storage and handling controls from verified material evidence.
  • Flag a lot for quarantine or retesting after an excursion or unresolved identity result.
  • Link ingredient quantities to containing products while preserving the distinction between ester mass and estradiol-equivalent reporting.
  • Route formulation suitability and clinical-use questions to the relevant product and treatment models.

Hazards and failure modes required Filled

  • Raises the risk of blood clots, stroke and some cancers.
  • Unsupervised use can lead to dangerous hormone levels.

Standards and interfaces required Filled

  • European Pharmacopoeia monograph on estradiol valerate, European Directorate for the Quality of Medicines and HealthCare.

Context of use required Filled

  • Estradiol valerate is encountered in estrogen-containing medicines, including oral and injectable formulations.
  • Pharmaceutical manufacturing, quality control and research use its chemical identity to distinguish the ester from estradiol and other estrogen esters.

Sources Filled

  1. Wikidata item Q5401768: estradiol valerate - identity and sense of the item
  2. Wikipedia: Estradiol valerate - general description of the item

Open questions

  • Which authoritative records confirm the CAS, EC and UNII mappings against the complete stereochemical structure?
  • Which current pharmacopoeial monographs apply, and what assay, related-substance and residual limits do they require?
  • Which experimentally supported solid forms, melting intervals, solubilities and decomposition data exist, and which reported constants are estimates?
  • What bulk-material stability evidence supports storage conditions and retest periods independently of finished injection or tablet labels?
  • Which jurisdiction-specific GHS classifications, occupational exposure limits and environmental disposal requirements are established for estradiol valerate?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q5401768/spec.json